Drugs / TJO-018
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT04127851 | Nov 2019 → Jul 2021 | dry eye syndrome | Taejoon Pharmaceutical Co., Ltd. | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | TJO-018 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04127851 ↗ |
| Route | Other | “TJO-018 / one drop / 6 times daily in both eyes” NCT04127851 ↗ |